Furthermore, BEP inhibited EMT of breast cancer cells, which was determined by an increased gene expression of the epithelial gene, keratin 19, and decreased gene expression of the mesenchymal gene, vimentin when compared to control (Figure 6c–e). This evidence concerns the gene KRT19 and breast cancer.